Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_assertion type Assertion NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_head.
- NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_assertion wasGeneratedBy ECO_0000203 NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_provenance.
- NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_assertion wasDerivedFrom befree-2016 NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_provenance.
- NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_assertion SIO_000772 19614763 NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_provenance.
- NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_assertion evidence source_evidence_literature NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_provenance.
- NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_assertion description "[Adenocarcinomas (8.5%), large cell neuroendocrine carcinomas (20%) and squamous cell carcinomas (29.6%) displayed an intermediate percentage of positive cases, suggesting a gradient of Cav-1 expression according to tumour histotype-related aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752011.RAJeV-ADzfdzjEJWSX7jSQXecGwPsATawxmzv0ZhnN4UQ130_provenance.